East Africa
The USAID/East Africa regional Mission focuses on seven countries, five of which are
high-burden tuberculosis (TB) countries (Democratic Republic of the Congo, Ethiopia,
Kenya, Uganda, and Tanzania). USAID/East Africa also has a mandate to provide
technical assistance to USAID limited-presence countries (Burundi, Comoros, Djibouti
and Somalia). Sudan receives TB funds because the country is rebuilding services after
30 years of war. Djibouti also receives limited TB funding due to its key role in the
U.S. Government war on terrorism. The seven focus countries accounted for 11
percent of the global TB burden in 2006. DOTS (directly observed treatment, short
course) case detection rates in the five TB priority countries range from a low of 27
percent in Ethiopia to a high of 70 percent in Kenya, the only African country in East
and Central Africa meeting the World Health Organization’s (WHO’s) global target.
Efforts to assess improvements in case detection in the Africa Region have been
confounded by the increased number of people testing for HIV/AIDS and TB and by
lack of access to TB smear microscopy centers. For example, in Kenya, when sputum
smear positive notifications increased from 92 to 107 per 100,000 between 2000 and
2006, this was mostly due to an increase in case detection rather than an increase in
TB incidence linked to HIV. At the same time, the low case detection rates in Djibouti,
Ethiopia, and Sudan are due to lack of access to laboratory diagnostic services. The
USAID/East Africa subregion has both high HIV prevalence (adult HIV prevalence rate
equal to or greater than 4 percent) and low HIV prevalence subregions, and works to
implement appropriate strategies in these different contexts. In the TB priority
countries with high TB-HIV/AIDS co-infection rates, considerable focus has been placed
on strengthening TB-HIV/AIDS interventions (e.g., offering HIV CT and cotrimoxazole
preventive treatment to clients in TB programs and screening HIV-positive patients for
TB signs and symptoms, providing TB treatment to those with active disease and
isoniazid preventive treatment to those with latent TB, and improving infection control
in congregate settings).
Key issues in the region include a lack of focus on delivering high-quality DOTS, which
has increased the spread of MDR-TB. Laboratory infrastructure remains weak
throughout the region; currently on the African continent only South Africa has the
capacity to diagnose multidrug-resistant (MDR) and extensively drug-resistant (XDR)
TB. MDR-TB had initially not been a problem for East and Central Africa, but as
national TB programs change their drug regimen to include rifampicin in both the
intensive and continuation phases, MDR-TB rates have been rising and countries are
faced with the need to both access second-line drugs and conduct MDR-TB surveys to
assess the true extent of the problem.
USAID Approach and Key Activities
|
|
USAID/East Africa’s regional program has a mandate to build the capacity of African
regional institutions, and has sought African partners to improve, expand, and enhance
DOTS programs since 2002. Recognizing the need for improving the quality of DOTS
provision, USAID is working with the Regional Centre for Quality of Health Care
(RCQHC) to strengthen health workers’ skills and capacity. USAID/East Africa
provides technical assistance to support countries in implementing the current WHO
strategy to improve community-based DOTS (C-DOTS) to prevent and control TB,
increase public-private partnerships, and fully scale up TB-HIV/AIDS collaborative
activities. In addition, regional funds support RCQHC to work on pediatric TB, which
has not received the focus it deserves. Future activities will focus on establishing a Center of Excellence for MDR-TB to provide health staff of countries with a high burden of MDR-TB an opportunity to study and
implement DOTS for MDR-TB. USAID assistance includes the following:
- Leading efforts to put the re-emerging threat of TB on the forefront of the agenda of African Ministries of Health and
supporting Ministers to scale up interventions to better manage TB-HIV/AIDS
- Improving the quality of DOTS by training personnel to ensure that patients are on appropriate drugs and are adhering
to the full TB regimen
- Providing technical assistance to countries to upgrade and fully expand functional external quality assurance systems for
TB laboratory services
- Advocating at the national and international levels for higher and sustained political commitment to TB control
- Developing standard operating procedures for National Tuberculosis Reference Laboratories and strengthening their
capacity to further the development of a Supranational Reference Laboratory in the East Africa region
- Providing technical assistance to improve existing laboratory techniques and introducing new techniques, including
fluorescence microscopy, liquid culture, and drug sensitivity testing (DST) and DST of second- line drugs
- Increasing information and awareness of pediatric TB among TB program managers in order to develop a more focused
response to increasing cases of pediatric TB-HIV/AIDS co-infections
- Building capacity of the RCQHC to provide training on MDR-TB and to conduct operational research
- Establishing “collaboratives” to link TB staff from different countries in a network to improve TB control and treatment
- Expanding C-DOTS to bring TB services and increased awareness of TB to the community level
USAID Program Achievements
Since the initiation of support, USAID supported the following achievements:
- Trained 255 participants in DOTS expansion, case management of MDR-TB, and the integration of TB into focused antenatal care (ANC) clinics in Kenya, Uganda, Ethiopia in fiscal year 2007, exceeding the TB training target by 78
percent
- Developed guidelines on how to measure the quality of TB services from the patient’s perspective and how to integrate
TB into focused ANC clinics
- Developed guidelines and introduced new programmatic approaches addressing pediatric TB and developed standard
operating procedures for National Tuberculosis Reference Laboratories
- Supported drug resistance surveys in the Democratic Republic of the Congo
- Supported Ethiopia in the development of a grant from the Green Light Committee for MDR-TB treatment
Partnerships
Forming partnerships has been one of the most important elements in combating TB the Region. USAID implements the Tuberculosis Control Assistance Program through the KNCV Tuberculosis Foundation. In addition to USAID, international collaborators that have invested in efforts to improve TB control include the WHO, KNCV Tuberculosis Foundation, International Union Against Tuberculosis and Lung Disease, Management Sciences for Health, and RCQHC. The Global Fund to
Fight AIDS, Tuberculosis and Malaria is one of the major donors to national TB programs in East and Central Africa. Global Fund
resources from Round 6 are programmed to support the National Tuberculosis Reference Laboratory and the laboratory
network system in Uganda and Tanzania. The Foundation for Innovative New Diagnostics is also operating in the above countries
and Ethiopia.
January 2009
Related Links
|